So HT, $1 billion in upfronts and milestones and 12-15% royalty rate to POH for oxypatch and oxymorphone patch gains Pfizer up to $4.5 billion pa market and a growth one at that.
Also possible options for future opiod patches. Maybe Diclofenac and lidocaine for a few hundred million extra??
Sounds cheap.
oxymorphone trials begin, page-22
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 24725503 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 35141413 | 20 |
View Market Depth
| Last trade - 16.12pm 16/10/2024 (20 minute delay) ? |
| AVE (ASX) Chart |
Day chart unavailable